endo 1_v2


The prevalence of diseases requiring the use of endovascular devices increases with age. Patients requiring such devices are usually white males over the age of 60. Recently, however, as the American baby boomer population has started to age, the largest increase in usage of endovascular devices has been in Hispanic, African American, and other minority populations.

With over 20% of the US population projected to be over the age of 60 by 2020, the endovascular device market is expected to be the next billion-dollar medical device sector.

Emerging Technological Trends

The Endovascular Medical Device sector is making vast improvements in both the quality and efficiency of endografts. Large leaps in development have been particularly seen in the innovation of aortic endografts to address the domestic rise in both Abdominal Aortic Aneurysms (AAA) and Thoracic Aortic Disease (TAD).

Endovascular Medical Device companies are creating endografts that are minimally invasive and highly flexible. The smaller, less invasive nature of emerging endografts have decreased the amount of open surgeries needed to address endovascular concerns, thus vastly decreasing surgical complications and incidents of mortality.

The move from endografts that need to be custom fit per patient to more flexible designs have allowed a greater variety of individuals to receive these devices at a reduced cost to both physicians and patients.




The Impact of IoT on Endovascular Devices

The largest technology trend predicted to drive growth and development in Endovascular Medical Device sector is the integration of these devices into a connected platform. Both end users and physicians alike are increasingly demanding that the devices implanted in and used by patients have remotely accessible qualities, primarily in the form of monitoring.

These monitoring capabilities manifest in mobile devices that allow physicians to easily track patient vitals and securely access and transfer health records and data. Remote monitoring of endovascular devices is more efficient and cost saving for both patients and physicians/hospitals.

Devices with these capabilities have been found to decrease the annual cost per patient by up to 54.87%. Money is primarily saved by reducing incidents of hospitalization and maintenance costs, as most upkeep and tracking of a patient’s vitals and status can be done from the comfort of a tablet or mobile device.


Saritasa: Your Digital Endovascular Tech Partner

Saritasa efficiently implements the design, development and integration of complex technologies to deliver cost-effective mobile-to-medical device connectivity solutions that are FDA/HIPAA compliant.

Founded in 2005 and located in Newport Beach, CA, Saritasa has increasingly become the single-point-of-contact to deliver end-to-end solutions that integrate, IoT, Mobile Apps, Medical Device Connectivity Solutions, Cloud Services Integrations, Big Data, Analytics, and Reporting Solutions.

Our clients include some of the leading Endovascular Medical Device makers that have come to rely on our expertise, reliability and speed for bringing innovative ideas to reality. To date, our innovative team of 140 designers, developers, engineers, and project managers has delivered hundreds of successful software, hardware, and mobile app projects to the Medical Device industry.


main image